Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 994 entries
View as:

A Study to Evaluate the Use of Apremilast in Patients With Psoriatic Arthritis, Naïve to Biological Treatment

Phase: N/A Priority: Normal
NCT ID: NCT03828045 Org: User:
Start: 02/06/19 End: 10/20/21 Due: 10/20/22

Darbepoetin Alfa in Patients With Anemic Low or Intermediate-1 Risk Myelodysplastic Syndrome (MDS)

Phase: N/A Priority: Normal
NCT ID: NCT01362140 Org: User:
Start: 12/21/11 End: 09/14/17 Due: 09/14/18

Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT01345019 Org: User:
Start: 05/17/12 End: 03/29/19 Due: 03/29/20

A Phase 1 Study Evaluating the Safety, Tolerability and Efficacy of AMG 119 in Subjects With RR SCLC

Phase: N/A Priority: Normal
NCT ID: NCT03392064 Org: User:
Start: 09/10/18 End: 01/14/27 Due: 01/14/28

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 282 in Healthy Subjects and Subjects With Chronic Rhinosinusitis With Nasal Polyps

Phase: N/A Priority: Normal
NCT ID: NCT02170337 Org: User:
Start: 07/31/14 End: 05/31/16 Due: 05/31/17

Etanercept Plus Methotrexate Versus Methotrexate Alone in Children With Polyarticular Course Juvenile Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT03781375 Org: User:
Start: 08/24/00 End: 06/24/02 Due: 06/24/03

Study To Evaluate the Status of Subjects That Discontinued Participation in a Qualifying Amgen Sponsored AMG 073 Study Due to Kidney Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT00110656 Org: User:
Start: 03/31/04 End: 10/31/04 Due: 10/31/05

Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone

Phase: N/A Priority: Normal
NCT ID: NCT00339183 Org: User:
Start: 06/30/06 End: 11/01/10 Due: 11/01/11

Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma

Phase: N/A Priority: Normal
NCT ID: NCT01395485 Org: User:
Start: 06/30/11 End: 06/30/12 Due: 06/30/13

PRISM (Panitumumab Regimen In Second-line Monotherapy of Head and Neck Cancer)

Phase: N/A Priority: Normal
NCT ID: NCT00446446 Org: User:
Start: 10/30/07 End: 11/29/17 Due: 11/29/18

To Evaluate the Preliminary Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of CC-11050 in Subjects With Discoid Lupus Erythematosus and Subacute Cutaneous Lupus Erythematosus

Phase: N/A Priority: Normal
NCT ID: NCT01300208 Org: User:
Start: 10/01/10 End: 03/01/13 Due: 03/01/14

Safety and Efficacy of Efavaleukin Alfa in Participants With Moderately to Severely Active Ulcerative Colitis

Phase: N/A Priority: Normal
NCT ID: NCT04987307 Org: User:
Start: 01/31/22 End: 10/22/24 Due: 10/22/25

Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease

Phase: N/A Priority: Normal
NCT ID: NCT00093977 Org: User:
Start: 10/31/04 End: 01/31/07 Due: 01/31/08

Denosumab Safety Assessment in Multiple Observational Databases

Phase: N/A Priority: Normal
NCT ID: NCT02520362 Org: User:
Start: 05/31/10 End: 07/21/23 Due: 07/21/24

A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00813384 Org: User:
Start: 12/31/08 End: 12/31/14 Due: 12/31/15

A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00117247 Org: User:
Start: 06/30/02 End: 07/31/04 Due: 07/31/05

Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease

Phase: N/A Priority: Normal
NCT ID: NCT04528082 Org: User:
Start: 09/09/21 End: 12/17/30 Due: 12/17/31

A Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) in Chronic Migraine Prevention

Phase: N/A Priority: Normal
NCT ID: NCT02066415 Org: User:
Start: 03/05/14 End: 04/28/16 Due: 04/28/17

Study of Addition of Panitumumab to Chemoradiation Therapy in Patients With Locally Advanced Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00500760 Org: User:
Start: 10/01/07 End: 04/26/11 Due: 04/26/12

Heart Failure Study to Evaluate Vital Signs and Overcome Low Use of Guideline-Directed Therapy by Remote Monitoring

Phase: N/A Priority: Normal
NCT ID: NCT04292275 Org: User:
Start: 03/06/20 End: 10/01/21 Due: 10/01/22

Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Phase: N/A Priority: Normal
NCT ID: NCT05995691 Org: User:
Start: 11/24/14 End: 12/04/15 Due: 12/04/16

A Study of Ivabradine in African-American/ Black Subjects With Heart Failure and Left Ventricular Systolic Dysfunction.

Phase: N/A Priority: Normal
NCT ID: NCT03456856 Org: User:
Start: 09/28/17 End: 05/20/19 Due: 05/20/20

A Double-blind Study to Assess the Efficacy and Safety of Denosumab Produced by Two Different Processes in Postmenopausal Women With Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT02157948 Org: User:
Start: 05/31/14 End: 07/31/15 Due: 07/31/16

Safety and Efficacy Study of AMG 073 in Hemodialysis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT00527267 Org: User:
Start: 02/28/02 End: 04/30/03 Due: 04/30/04

Long Term Post Marketing Specified Drug Use Result Survey for Evolocumab in Japan

Phase: N/A Priority: Normal
NCT ID: NCT02808403 Org: User:
Start: 06/24/16 End: 03/30/23 Due: 03/30/24